STSG-0002 Injection

DRUG2 trials

Sponsors

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Conditions

Chronic Hepatitis b

Phase 2

To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

TerminatedNCT05760781

Staidson (Beijing) Biopharmaceuticals Co., LtdChronic Hepatitis b

Start: 2023-04-25End: 2023-12-11Updated: 2023-12-19

Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

TerminatedNCT05760703

Staidson (Beijing) Biopharmaceuticals Co., LtdChronic Hepatitis b

Start: 2023-04-25End: 2023-12-11Updated: 2023-12-19